gold has been researched along with rivaroxaban in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshar Mogaddam, MR; Barzegari, A; Ebrahimi, R; Hasanzadeh, M; Jouyban, A; Jouyban-Gharamaleki, V; Khoubnasabjafari, M; Kordasht, HK; Rad, AA; Rashidi, MR; Shadjou, N; Teimuri-Mofrad, R | 1 |
1 other study(ies) available for gold and rivaroxaban
| Article | Year |
|---|---|
Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Limit of Detection; Metal Nanoparticles; Rivaroxaban | 2022 |